Annual SGA
$4.13 M
-$295.40 K-6.67%
September 30, 2024
Summary
- As of February 12, 2025, EDSA annual SGA is $4.13 million, with the most recent change of -$295.40 thousand (-6.67%) on September 30, 2024.
- During the last 3 years, EDSA annual SGA has fallen by -$1.60 million (-27.93%).
- EDSA annual SGA is now -27.93% below its all-time high of $5.73 million, reached on September 30, 2021.
Performance
EDSA SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$900.50 K
-$134.60 K-13.00%
September 30, 2024
Summary
- As of February 12, 2025, EDSA quarterly SGA is $900.50 thousand, with the most recent change of -$134.60 thousand (-13.00%) on September 30, 2024.
- Over the past year, EDSA quarterly SGA has dropped by -$143.60 thousand (-13.75%).
- EDSA quarterly SGA is now -77.46% below its all-time high of $4.00 million, reached on February 28, 2011.
Performance
EDSA Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$226.27 M
-$6.17 M-2.80%
September 30, 2024
Summary
- As of February 12, 2025, EDSA TTM SGA is -$226.27 million, with the most recent change of -$6.17 million (-2.80%) on September 30, 2024.
- Over the past year, EDSA TTM SGA has dropped by -$230.92 million (-4963.98%).
- EDSA TTM SGA is now -237082.60% below its all-time high of -$95.40 thousand.
Performance
EDSA TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
EDSA Selling, General & Administrative Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -6.7% | -13.8% | -4964.0% |
3 y3 years | -27.9% | -13.3% | -5680.9% |
5 y5 years | +102.1% | -13.3% | -5680.9% |
EDSA Selling, General & Administrative Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -27.9% | at low | -41.2% | at low | -130.3% | at low |
5 y | 5-year | -27.9% | +102.1% | -44.0% | +32.1% | -886.9% | at low |
alltime | all time | -27.9% | +5164.7% | -77.5% | +157.3% | <-9999.0% | at low |
Edesa Biotech Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | $4.13 M(-6.7%) | $900.50 K(-13.0%) | $4.13 M(-11.1%) |
Jun 2024 | - | $1.04 M(-0.9%) | $4.65 M(-0.1%) |
Mar 2024 | - | $1.04 M(-9.4%) | $4.65 M(+2.0%) |
Dec 2023 | - | $1.15 M(-18.6%) | $4.56 M(+3.0%) |
Sep 2023 | $4.43 M(-12.1%) | $1.42 M(+36.4%) | $4.43 M(+9.2%) |
Jun 2023 | - | $1.04 M(+9.1%) | $4.05 M(-5.0%) |
Mar 2023 | - | $952.40 K(-6.7%) | $4.27 M(-12.0%) |
Dec 2022 | - | $1.02 M(-2.1%) | $4.85 M(-3.8%) |
Sep 2022 | $5.04 M(-12.2%) | $1.04 M(-16.6%) | $5.04 M(-5.9%) |
Jun 2022 | - | $1.25 M(-18.4%) | $5.35 M(-6.3%) |
Mar 2022 | - | $1.53 M(+26.6%) | $5.71 M(-0.0%) |
Dec 2021 | - | $1.21 M(-10.8%) | $5.71 M(-0.4%) |
Sep 2021 | $5.73 M(+69.5%) | $1.36 M(-15.6%) | $5.73 M(+9.6%) |
Jun 2021 | - | $1.61 M(+4.8%) | $5.23 M(+20.1%) |
Mar 2021 | - | $1.54 M(+24.4%) | $4.36 M(+10.7%) |
Dec 2020 | - | $1.23 M(+44.5%) | $3.94 M(+16.3%) |
Sep 2020 | $3.38 M(+65.4%) | $853.90 K(+16.5%) | $3.38 M(+1.7%) |
Jun 2020 | - | $733.10 K(-34.2%) | $3.33 M(-2.5%) |
Mar 2020 | - | $1.11 M(+63.4%) | $3.41 M(-5.8%) |
Dec 2019 | - | $681.70 K(-14.6%) | $3.62 M(-5.3%) |
Sep 2019 | $2.05 M(-25.8%) | $798.30 K(-2.4%) | $3.82 M(+3.9%) |
Jun 2019 | - | $817.90 K(-38.3%) | $3.68 M(+4.7%) |
Mar 2019 | - | $1.33 M(+50.2%) | $3.51 M(+18.6%) |
Dec 2018 | - | $882.80 K(+35.0%) | $2.96 M(+7.4%) |
Sep 2018 | $2.76 M(-6.4%) | $653.70 K(+0.4%) | $2.76 M(+0.8%) |
Jun 2018 | - | $651.20 K(-15.9%) | $2.73 M(+0.6%) |
Mar 2018 | - | $774.00 K(+14.1%) | $2.72 M(+1.0%) |
Dec 2017 | - | $678.50 K(+7.6%) | $2.69 M(-8.6%) |
Sep 2017 | $2.94 M(-11.4%) | $630.80 K(-0.8%) | $2.94 M(-3.2%) |
Jun 2017 | - | $635.70 K(-14.8%) | $3.04 M(-2.7%) |
Mar 2017 | - | $746.40 K(-19.9%) | $3.13 M(-0.6%) |
Dec 2016 | - | $932.10 K(+28.1%) | $3.15 M(-5.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2016 | $3.32 M(+3.0%) | $727.60 K(+1.0%) | $3.32 M(-4.4%) |
Jun 2016 | - | $720.40 K(-5.8%) | $3.48 M(+3.0%) |
Mar 2016 | - | $765.10 K(-31.1%) | $3.37 M(-0.6%) |
Dec 2015 | - | $1.11 M(+25.9%) | $3.40 M(+5.2%) |
Sep 2015 | $3.23 M(+1001.2%) | $881.50 K(+42.6%) | $3.23 M(+37.9%) |
Jun 2015 | - | $618.20 K(-21.3%) | $2.34 M(-8.1%) |
Mar 2015 | - | $785.70 K(-16.6%) | $2.55 M(-2.6%) |
Dec 2014 | - | $942.20 K(<-9900.0%) | $2.61 M(-9.0%) |
Sep 2014 | $293.10 K(-89.8%) | - | - |
Aug 2014 | $2.87 M(+62.2%) | -$6000.00(-100.7%) | $2.87 M(-2.2%) |
May 2014 | - | $823.90 K(-3.4%) | $2.94 M(+9.4%) |
Feb 2014 | - | $853.30 K(-28.9%) | $2.68 M(+12.4%) |
Nov 2013 | - | $1.20 M(+1951.6%) | $2.39 M(+34.8%) |
Aug 2013 | $1.77 M(-51.6%) | $58.50 K(-89.8%) | $1.77 M(-15.0%) |
May 2013 | - | $571.00 K(+2.5%) | $2.08 M(-23.6%) |
Feb 2013 | - | $556.90 K(-4.7%) | $2.73 M(-12.4%) |
Nov 2012 | - | $584.20 K(+57.1%) | $3.11 M(-14.9%) |
Aug 2012 | $3.66 M(+0.4%) | $371.80 K(-69.4%) | $3.66 M(+113.2%) |
May 2012 | - | $1.21 M(+28.7%) | $1.72 M(+32.3%) |
Feb 2012 | - | $943.90 K(-16.6%) | $1.30 M(-70.2%) |
Nov 2011 | - | $1.13 M(-171.9%) | $4.35 M(+19.3%) |
Aug 2011 | $3.65 M(+212.3%) | -$1.57 M(-297.7%) | $3.65 M(-36.9%) |
May 2011 | - | $795.60 K(-80.1%) | $5.78 M(+7.7%) |
Feb 2011 | - | $4.00 M(+831.2%) | $5.37 M(+287.4%) |
Nov 2010 | - | $429.10 K(-23.7%) | $1.39 M(+39.5%) |
Aug 2010 | $1.17 M(+1388.0%) | $562.40 K(+46.6%) | $994.10 K(+130.3%) |
May 2010 | - | $383.70 K(+3295.6%) | $431.70 K(+700.9%) |
Jan 2010 | - | $11.30 K(-69.2%) | $53.90 K(+12.1%) |
Oct 2009 | - | $36.70 K(+522.0%) | $48.10 K(-36.7%) |
Apr 2009 | $78.50 K | $5900.00(+7.3%) | $76.00 K(+8.4%) |
Jan 2009 | - | $5500.00(-91.5%) | $70.10 K(+8.5%) |
Oct 2008 | - | $64.60 K | $64.60 K |
FAQ
- What is Edesa Biotech annual SGA?
- What is the all time high annual SGA for Edesa Biotech?
- What is Edesa Biotech annual SGA year-on-year change?
- What is Edesa Biotech quarterly SGA?
- What is the all time high quarterly SGA for Edesa Biotech?
- What is Edesa Biotech quarterly SGA year-on-year change?
- What is Edesa Biotech TTM SGA?
- What is the all time high TTM SGA for Edesa Biotech?
- What is Edesa Biotech TTM SGA year-on-year change?
What is Edesa Biotech annual SGA?
The current annual SGA of EDSA is $4.13 M
What is the all time high annual SGA for Edesa Biotech?
Edesa Biotech all-time high annual SGA is $5.73 M
What is Edesa Biotech annual SGA year-on-year change?
Over the past year, EDSA annual SGA has changed by -$295.40 K (-6.67%)
What is Edesa Biotech quarterly SGA?
The current quarterly SGA of EDSA is $900.50 K
What is the all time high quarterly SGA for Edesa Biotech?
Edesa Biotech all-time high quarterly SGA is $4.00 M
What is Edesa Biotech quarterly SGA year-on-year change?
Over the past year, EDSA quarterly SGA has changed by -$143.60 K (-13.75%)
What is Edesa Biotech TTM SGA?
The current TTM SGA of EDSA is -$226.27 M
What is the all time high TTM SGA for Edesa Biotech?
Edesa Biotech all-time high TTM SGA is -$95.40 K
What is Edesa Biotech TTM SGA year-on-year change?
Over the past year, EDSA TTM SGA has changed by -$230.92 M (-4963.98%)